Hims & Hers Health (NYSE:HIMS) versus Clover Health Investments (NASDAQ:CLOV) Head to Head Survey

Clover Health Investments (NASDAQ:CLOV) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Volatility & Risk

Clover Health Investments has a beta of 2.07, suggesting that its share price is 107% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.2, suggesting that its share price is 120% more volatile than the S&P 500.

Profitability

This table compares Clover Health Investments and Hims & Hers Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	-3.29%	-16.79%	-9.95%
Hims & Hers Health	6.05%	24.67%	9.37%

Valuation and Earnings

This table compares Clover Health Investments and Hims & Hers Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$1.37 billion	0.92	-$43.01 million	($0.11)	-22.45
Hims & Hers Health	$1.48 billion	5.55	$126.04 million	$0.54	66.67

Hims & Hers Health has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations for Clover Health Investments and Hims & Hers Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	1	2	2	1	2.50
Hims & Hers Health	3	10	2	0	1.93

Clover Health Investments currently has a consensus target price of $3.93, indicating a potential upside of 58.91%. Hims & Hers Health has a consensus target price of $45.27, indicating a potential upside of 25.75%. Given Clover Health Investments’ stronger consensus rating and higher possible upside, analysts plainly believe Clover Health Investments is more favorable than Hims & Hers Health.

Insider & Institutional Ownership

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 24.1% of Clover Health Investments shares are held by company insiders. Comparatively, 13.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Hims & Hers Health beats Clover Health Investments on 10 of the 14 factors compared between the two stocks.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.